Dolutegravir
New Research on Dolutegravir Treatment in HIV Patients Showcases Promise in Brazil
A team of investigators from Federal University Bahia conducted a comprehensive study on the clinical outcomes of dolutegravir (DTG) treatment in people living with HIV in Brazil. The research, known as the Clinical Outcomes of Dolutegravir Treatment in People Living with HIV in Brazil (CODE) cohort study, aims to assess